Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2018 / N 3

Ведение коморбидных пациентов с сердечно-сосудистыми заболеваниями
Г.Б. Селиванова, Н.Г. Потешкина

Список литературы
1. World Health Organization: regional office for Europe. Cardiovascular diseases. Available from: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases Accessed 2018 Nov 06.
2. Всемирная организация здравоохранения. Сердечно-сосудистые заболевания. Информационный бюллетень. Доступно по: http://www.who.int/mediacentre/factsheets/fs317/ru/ Ссылка активна на 06.11.2018.
3. World Health Organization: regional office for Europe. Noncommunicable diseases. Available from: http://www.euro.who.int/en/health-topics/noncommunicable-diseases Accessed 2018 Nov 06.
4. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC. The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology 2011 Sep;21(9):655-79.
5. Всемирная организация здравоохранения. Инвестиции в лечение депрессии и тревожных расстройств окупаются в четырехкратном размере. http://www.who.int/mediacentre/news/releases/2016/depression-anxiety-treatment/ru/ Ссылка активна на 06.11.2018.
6. Всемирная организация здравоохранения. Психические расстройства. Информационный бюллетень. Доступно по: http://www.who.int/mediacentre/factsheets/fs396/ru Ссылка активна на 06.11.2018.
7. Всемирная организация здравоохранения. Депрессия. Информационный бюллетень. http://www.who.int/mediacentre/factsheets/fs369/ru/ Ссылка активна на 06.11.2018.
8. Национальный исследовательский университет «Высшая школа экономики». Научно-образовательный портал IQ. Смертность снижается неравномерно. https://iq.hse.ru/news/177666488.html Ссылка активна на 06.11.2018.
9. Котова О.В., Акарачкова Е.С. Сочетание сердечно-сосудистых заболеваний и тревоги у пожилых пациентов: как повысить эффективность лечения и качество жизни. Русский медицинский журнал 2018;1(2):95-9.
10. Gili M, Comas A, García-García M, Monzón S, Antoni SB, Roca M. Comorbidity between common mental disorders and chronic somatic diseases in primary care patients. General Hospital Psychiatry 2010 May-June;32(3):240-5.
11. Федотова А.В. Тревожно-депрессивные расстройства в общеклинической практике. Рациональная фармакотерапия в кардиологии 2008;4(3):83-7.
12. Погосова Г.В. Психоэмоциональные расстройства у больных сердечно-сосудистыми заболеваниями: вопросы лечения. Кардоваскулярная терапия и профилактика 2006;5(2):94-9.
13. Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. International Journal of Stroke 2013 Oct;8(7):545-59.
14. Gan Y, Gong Y, Tong X, Sun H, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014;14:371.
15. Медведев В.Э. Терапия тревожных расстройств у пациентов с сердечно-сосудистыми заболеваниями (опыт применения афобазола). Архивъ внутренней медицины 2013;3(11):70-6.
16. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep;364(9438):937-52.
17. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry 2011 May-June;33(3):203-16.
18. Kotseva K, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Abreu A, Aguiar C, Conde AC, Davletov K, Dilic M, Dolzhenko M, Gaita D, Georgiev B, Gotcheva N, Lalic N, Laucevicius A, Lovic D, Mancas S, Miličić D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Vulic D, Wood D; on behalf of the Euroaspire Investigators. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on secondary and primary prevention by intervention to reduce events (EUROASPIRE) IV cross-sectional survey in 14 European regions. European Journal of Preventive Cardiology 2016 Dec;23(18):2007-18.
19. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Current Psychiatry Reports 2016 Nov;18(11):101.
20. Yasunari K, Matsui T, Maeda K, Nakamura M, Watanabe T, Kiriike N. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. American Journal of Hypertension 2006 Jun;19(6):573-8.
21. Оздоева Л. Д., Небиеридзе Д. В., Погосова Г.В., Выгодин В.А., Иванишина Н.С., Оганов Р.Г. Взаимосвязь факторов риска атеросклероза и тревожно-депрессивных состояний у мужчин из неорганизованной популяции. Кардиоваскулярная терапия и профилактика 2003;2(1):59-64.
22. Piccirillo G, Viola E, Nocco M, Santagada E, Durante M, Bucca C, Marigliano V. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertension 1999 Aug;34(2):242-6.
23. Кириченко А.А. Депрессия, беспокойство и сердечно-сосудистая система. Лечащий врач 2002;12:58-61.
24. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Archives of General Psychiatry 2008 Jan;65(1):62-71.
25. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014 Mar;129(12):1350-69.
26. Nekouei ZK, Yousefy A, Manshaee G, Nikneshan S. Comparing anxiety in cardiac patients candidate for angiography with normal population. ARYA Atherosclerosis 2011 Fall;7(3):93-6.
27. Yadav M, Palmerini T, Caixeta A, Madhavan MV, Sanidas E, Kirtane AJ, Stone GW, Généreux P. Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. Journal of the American College of Cardiology 2013 Oct;62(14):1219-30.
28. Assari Sh, Zandi H, Ahmadi Kh, Saleh D.K. Extent of coronary stenosis and anxiety symptoms among patients undergoing coronary angiography. The Journal of Tehran University Heart Centre 2017 Oct;12(4):155-9.
29. Gustad LT, Bjerkeset O, Strand LB, Janszky I, Salvesen Ø, Dalen H. Cardiac function associated with previous, current and repeated depression and anxiety symptoms in a healthy population: the HUNT study. Open Heart 2016 Feb;3(1):e000363.
30. Borregaard B, Ekholm O, Riber L, Sørensen J, Møller JE, Thrysoe L, Thorup CB, Vámosi M, Christensen AV, Rasmussen TB, Berg SK. Patient-reported outcomes after aortic and mitral valve surgery – results from the DenHeart Study. European Journal of Cardiovascular Nursing 2018 Mar;17(3):246-54.
31. Berg SK, Thorup CB, Borregaard B, Christensen AV, Thrysoee L, Rasmussen TB, Ekholm O, Juel K, Vamosi M. Patient-reported outcomes are independent predictors of one-year mortality and cardiac events across cardiac diagnoses: Findings from the national DenHeart survey. European Journal of Preventive Cardiology 2018 Jan:2047487318769766. doi: 10.1177/2047487318769766. [Epub ahead of print].
32. Всемирная организация здравоохранения. Диабет. Информационный бюллетень ВОЗ. http://www.who.int/news-room/fact-sheets/detail/diabetes Ссылка активна на 06.11.2018.
33. Аметов А.С., Курочкин И.О., Зубков А.А. Сахарный диабет и сердечно-сосудистые заболевания. Русский медицинский журнал 2014;22(13):954-9.
34. Niefeld MR, Braunstein JB, Wu AW, Saudek CD, Weller WE, Anderson GF. Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care 2003 May;26(5):1344-9.
35. Один В.И., Беликова Т.И., Шустов С.Б., Пушкова Э.С., Эмануэль В.Л. Полиморбидность и некоторые онтогенетические факторы у больных диабетом пожилого и старческого возраста. Биомедицинский журнал 2005 Сентябрь;6(165):564-76.
36. Kahl KG, Schweiger U, Correll C, Müller C, Busch ML, Bauer M, Schwarz P. Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Brain and Behavior 2015 Mar;5(3):e00306.
37. Chien IC, Lin CH. Increased risk of diabetes in patients with anxiety disorders: a population-based study. Journal of Psychosomatic Research 2016 Jul;86:47-52.
38. Зеленин К.А. Тревожные расстройства у больных сахарным диабетом 2 типа: Автореф. дис. … канд. мед. наук. Москва. 2011. 23 c.
39. Успенский Ю.П, Балукова Е.В. Патоморфоз тревожного расстройства у больных с дисбиозом кишечника. Лечащий врач 2009;7:70-4.
40. Ватутин Н.Т., Христиченко М.А., Картамышева Е.В., Кетинг Е.В. Тревожные расстройства и сердечно-сосудистые заболевания. Кровообращение и гемостаз 2013;(2):72-9.

References
1. World Health Organization: regional office for Europe. Cardiovascular diseases. Available from: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases Accessed 2018 Nov 06.
2. World Health Organization. Cardiovascular diseases (CVDs). Available from: http://www.who.int/mediacentre/factsheets/fs317/ru/ Accessed 2018 Nov 06 (In Russian).
3. World Health Organization: regional office for Europe. Noncommunicable diseases. Available from: http://www.euro.who.int/en/health-topics/noncommunicable-diseases Accessed 2018 Nov 06.
4. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC. The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology 2011 Sep;21(9):655-79.
5. World Health Organization. Investing in treatment for depression and anxiety leads to fourtfold return. Available from: http://www.who.int/mediacentre/news/releases/2016/depression-anxiety-treatment/ru/ Accessed 2018 Nov 06 (In Russian).
6. World Health Organization. Mental disorders. Available from: http://www.who.int/mediacentre/factsheets/fs396/ru. Accessed 2018 Nov 06 (In Russian).
7. World Health Organization. Depression. Available from: http://www.who.int/mediacentre/factsheets/fs369/ru/ Accessed 2018 Nov 06. (In Russian).
8. National Research University Higher School of Economics. IQ The mortality rate is reduced unevenly. Available from: https://iq.hse.ru/news/177666488.html Accessed 2018 Nov 06 (In Russian).
9. Kotova OV, Akarachkova ES. Combination of cardiovascular diseases and anxiety in elderly patients: how to improve efficacy of treatment and quality of life. Russian Medical Journal 2018;1(2):95-9 (In Russian).
10. Gili M, Comas A, García-García M, Monzón S, Antoni SB, Roca M. Comorbidity between common mental disorders and chronic somatic diseases in primary care patients. General Hospital Psychiatry 2010 May-June;32(3):240-5.
11. Fedotova AV. Anxiety and depression in general clinical practice. Rational Pharmacotherapy in Cardiology 2008;4(3):83-7 (In Russian).
12. Pogosova GV. Psychoemotional disorders in patients with cardiovascular diseases: treatment issues. Cardiovascular Therapy and Prevention 2006;5(2): 94-9 (In Russian).
13. Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. International Journal of Stroke 2013 Oct;8(7):545-59.
14. Gan Y, Gong Y, Tong X, Sun H, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014;14:371.
15. Medvedev VE. Therapy of anxiety disorders in patients with cardiovascular diseases: afobazole treatment. The Russian Archives of Internal Medicine 2013;3(11):70-6 (In Russian).
16. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep;364(9438):937-52.
17. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry 2011 May-June;33(3):203-16.
18. Kotseva K, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Abreu A, Aguiar C, Conde AC, Davletov K, Dilic M, Dolzhenko M, Gaita D, Georgiev B, Gotcheva N, Lalic N, Laucevicius A, Lovic D, Mancas S, Miličić D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Vulic D, Wood D; on behalf of the Euroaspire Investigators. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on secondary and primary prevention by intervention to reduce events (EUROASPIRE) IV cross-sectional survey in 14 European regions. European Journal of Preventive Cardiology 2016 Dec;23(18):2007-18.
19. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Current Psychiatry Reports 2016 Nov;18(11):101.
20. Yasunari K, Matsui T, Maeda K, Nakamura M, Watanabe T, Kiriike N. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. American Journal of Hypertension 2006 Jun;19(6):573-8.
21. Ozdoeva LD, Nebieridze DV, Pogosova GV, Vygodin VA, Ivanishina NS, Oganov RG. Relationship between atherosclerosis risk factors and male anxiety and depression. Cardiovascular Therapy and Prevention 2003;2(1):59-64 (In Russian).
22. Piccirillo G, Viola E, Nocco M, Santagada E, Durante M, Bucca C, Marigliano V. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertension 1999 Aug;34(2):242-6.
23. Kirichenko AA. Depression, anxiety and the cardiovascular system. Lechashchiy Vrach 2002;12:58-61 (In Russian).
24. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Archives of General Psychiatry 2008 Jan;65(1):62-71.
25. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014 Mar;129(12):1350-69.
26. Nekouei ZK, Yousefy A, Manshaee G, Nikneshan S. Comparing anxiety in cardiac patients candidate for angiography with normal population. ARYA Atherosclerosis 2011 Fall;7(3):93-6.
27. Yadav M, Palmerini T, Caixeta A, Madhavan MV, Sanidas E, Kirtane AJ, Stone GW, Généreux P. Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. Journal of the American College of Cardiology 2013 Oct;62(14):1219-30.
28. Assari Sh, Zandi H, Ahmadi Kh, Saleh D.K. Extent of coronary stenosis and anxiety symptoms among patients undergoing coronary angiography. The Journal of Tehran University Heart Centre 2017 Oct;12(4):155-9.
29. Gustad LT, Bjerkeset O, Strand LB, Janszky I, Salvesen Ø, Dalen H. Cardiac function associated with previous, current and repeated depression and anxiety symptoms in a healthy population: the HUNT study. Open Heart 2016 Feb;3(1):e000363.
30. Borregaard B, Ekholm O, Riber L, Sørensen J, Møller JE, Thrysoe L, Thorup CB, Vámosi M, Christensen AV, Rasmussen TB, Berg SK. Patient-reported outcomes after aortic and mitral valve surgery – results from the DenHeart Study. European Journal of Cardiovascular Nursing 2018 Mar;17(3):246-54.
31. Berg SK, Thorup CB, Borregaard B, Christensen AV, Thrysoee L, Rasmussen TB, Ekholm O, Juel K, Vamosi M. Patient-reported outcomes are independent predictors of one-year mortality and cardiac events across cardiac diagnoses: Findings from the national DenHeart survey. European Journal of Preventive Cardiology 2018 Jan:2047487318769766. doi: 10.1177/2047487318769766. [Epub ahead of print].
32. World Health Organization. Diabetes. Available from: http://www.who.int/news-room/fact-sheets/detail/diabetes Accessed 2018 Nov 06 (In Russian).
33. Ametov AS, Kurochkin IO, Zubkov AA. Diabetes mellitus and cardiovascular diseases. Russian Medical Journal 2014;22(13):954-9 (In Russian).
34. Niefeld MR, Braunstein JB, Wu AW, Saudek CD, Weller WE, Anderson GF. Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care 2003 May; 26(5):1344-9.
35. Odin VI, Belikova TI, Shustov SB, Pushkova ES, Emanuel VL. Polymorbidity and some ontogenetic factors in elderly and senile patients with diabetes. Biomedical Journal 2005 September; 6 (165): 564-76 (In Russian).
36. Kahl KG, Schweiger U, Correll C, Müller C, Busch ML, Bauer M, Schwarz P. Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Brain and Behavior 2015 Mar; 5(3):e00306.
37. Chien IC, Lin CH. Increased risk of diabetes in patients with anxiety disorders: a population-based study. Journal of Psychosomatic Research 2016 Jul;86:47-52.
38. Zelenin KA. Anxiety disorders in patients with diabetes mellitus type 2 [abstract from dissertation for the degree of Candidate of Medical Sciences]. Moscow, 2011. 23 p. (In Russian).
39. Uspenskiy YuP, Balukova EV. Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis. Lechashchiy Vrach 2009;7:70-4 (In Russian).
40. Vatutin NT, Khristichenko MA, Kartamysheva EV, Keting EV. Anxiety disorders and cardiovascular diseases. Circulation and Haemostasis 2013;2:72-9 (In Russian).

  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]